68Ga-PSMA-11 PET在前列腺切除床发现肿瘤复发:PSA升至0.9 ng/mL而MRI与18F-Fluciclovine PET阴性
63岁前列腺癌患者行前列腺切除术后PSA为0.6 ng/mL,盆腔MRI、全身骨扫描及胸腹部CT未见残留或转移。两个月后PSA升至0.9 ng/mL,18F-Fluciclovine PET未见示踪剂摄取病灶,左侧前列腺切除床0.7 cm非Fluciclovine摄取结节被认为良性。一个月后68Ga-PSMA-11 PET显示该结节有放射性示踪剂摄取,患者接受雄激素剥夺治疗后反应良好。
要点
- 前列腺切除术后PSA升至0.9 ng/mL而MRI、骨扫描、CT及18F-Fluciclovine PET均阴性时,68Ga-PSMA-11 PET可发现切除床复发。
- 左侧前列腺切除床0.7 cm结节在18F-Fluciclovine PET上无摄取、被认为良性,而68Ga-PSMA-11 PET显示该结节有摄取。
- 患者依据68Ga-PSMA-11 PET/CT结果接受雄激素剥夺治疗,反应良好。
核心结论
- 68Ga-PSMA-11 PET在前列腺切除术后PSA升至0.9 ng/mL、MRI及18F-Fluciclovine PET均阴性的患者中识别出前列腺切除床肿瘤复发。
研究设计与样本
- 本文为个案报告,报告1例63岁前列腺癌患者行前列腺切除术后生化复发、多种影像学检查阴性的诊治经过。
主要发现
- 患者前列腺切除术后PSA为0.6 ng/mL,盆腔MRI、全身骨扫描、胸部CT和腹部CT均未见残留或转移性前列腺病灶。
- 两个月后PSA升至0.9 ng/mL,18F-Fluciclovine PET未见任何示踪剂摄取的转移或复发病灶,左侧前列腺切除床0.7 cm非Fluciclovine摄取结节被认为良性。
- 一个月后68Ga-PSMA-11 PET显示该结节内有放射性示踪剂摄取。
- 患者在接受PSMA PET/CT后接受雄激素剥夺治疗,反应良好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 63-year-old man with prostate cancer was treated with prostatectomy who had postoperative PSA of 0.6 ng/mL. A pelvic MRI, whole body bone scan, CT chest and abdomen exams did not show any residual or metastatic prostate disease. His PSA increased to 0.9 ng/mL in two months. A fluciclovine PET did not show any tracer avid metastatic or recurrent disease. A 0.7 cm non-fluciclovine-avid nodule at the left prostatectomy bed was considered benign. A 68Ga-PSMA-11 PET one month later showed avid radiotracer uptake within this nodule. The patient received androgen deprivation treatment after PSMA PET/CT and responded well.
引用
- Xu G, Lu Y. 68Ga-PSMA-11 PET Identified Tumor Recurrence in Prostatectomy Bed With Rising PSA of 0.9 ng/mL but Negative on MRI and 18F-Fluciclovine PET Scan. Clin Nucl Med. 2022. PMID: 35020642. doi:10.1097/RLU.0000000000003994
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。